期刊文献+

低剂量氟尿嘧啶持续输注联合奥沙利铂治疗老年晚期胃肠道恶性肿瘤 被引量:1

Combined Continuous Infusion Fluorouracil with Low-dose and Oxaliplatin in Treatment for Senile Advanced Gastrointestinal Cancer
下载PDF
导出
摘要 [目的]观察低剂量氟尿嘧啶(5-Fu)持续输注联合奥沙利铂(L-OHP)方案治疗老年性晚期胃肠道恶性肿瘤的近期疗效及毒副反应等。[方法]32例晚期胃肠道恶性肿瘤患者给予5-Fu225mg/(m2·d)微量泵持续静脉滴注3周,L-OHP60mg/m2d1、8、15,静脉滴注,28d为1个周期,2个周期后评定疗效。[结果]CR1例,PR14例,NC13例,PD4例,32例病例的总有效率为46.88%(15/32),其中转移性肝癌患者有效率为64.71%(11/17)。化疗后ECOG评分比化疗前有显著性改善(P<0.05)。化疗后毒副反应病人均能耐受。[结论]低剂量氟尿嘧啶持续静脉输注联合奥沙利铂方案治疗老年性晚期胃肠道恶性肿瘤是一个有效、低毒,且能显著改善生活质量的化疗方案。 [Purpose] To evaluate the short-term efficacy and toxicities of the continuous central venous infusion (e.c.v.i) Fluoronracil with low-dose and Oxaliplatin in treatment for senile advanced gastrointestinal cancer. [Methods] 5-Fu 225mg/m^2·d c.c.v.i for 3 weeks, and Oxaliplatin 60mg/m^2 intravenous drip al d1.8.15 were administered in 32 patients with advanced gastrointestinal carcinoma. The regflnen was repeated every 28 days. The assessment was carried out after two cycles, [Results] One patient achieved complete response; 14, partial responses; 13, no change; and 4, progressive disease. The overall response rate was 46.88%(15/ 32). The response rate was 64.71% (11/17) in patient with liver metastasis. The score of ECOG was significantly improved than that before ehemotherapy(P〈0.05). The toxicities of chemotherapy were well tolerated. [Conclusions] Combined chemotherapy of continuous infusion 5-Fu with low-dose and Oxaliplatin in an effeetive, less toxicity regimen which can and improve the quality of life quality in senile advanced gastrointestinal cancer.
出处 《中国肿瘤》 CAS 2006年第5期346-348,共3页 China Cancer
关键词 药物疗法 胃肠肿瘤 奥沙利铂 drug therapy gastrointestinal neoplasms oxaliplatin
  • 相关文献

参考文献12

  • 1UICC(孙燕译).成人及儿童肿瘤内科分册[M].北京:学术期刊出版社,1988.29.
  • 2孙燕,周际昌.临床肿瘤内科分册[M].第3版.北京:人民卫生出版社,1996.30.
  • 3Likich JJ,Ahlgren JD,Phillips JA,et al.A prosperctive randomized comparison of continous infusion fluorouracil with a conventional bouls schedule in metastatic colorectal carcinoma:a mid-atlantic oncology program study[J].J Clin Oncol,1989,7(8):425.
  • 4Kondo K,Mrase,Kodera Y,et al.Feasibility study on protracted infusional 5-fluorouracil and consecutive low -dose cisplatin for advanced gastric cancer[J].J Oncology,1996,53(1):64-67.
  • 5陈嘉,陆建伟,陆禹溶,黄富麟.低剂量5-氟脲嘧啶持续输注治疗晚期肿瘤[J].临床肿瘤学杂志,1999,4(2):39-41. 被引量:7
  • 6沈波,陆禹溶,孙蔚莉.小剂量氟脲嘧啶持续滴注治疗老年晚期大肠癌疗效观察[J].江苏医药,2000,26(12):982-982. 被引量:1
  • 7Raymond E,Buquet-Fagot C,Djellal S,et al.Antitumor activity of oxaliplatin in combination with 5-fluorourail and the thymidylate synthase inhibitor AG337 in human colon,breast and ovarian cancers[J].J Anticancer Drugs,1997,8(9):876-885.
  • 8Bleiberg H.Oxaliplatin (L-OHP):a new reality in colorectal cancer[J].Br Cancer,1998,77(Suppl 4):1.
  • 9Gramont AD,Figer A,Seynour M,et al.Leucovorin and 5-fluorouracil or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].Clin Oncol,2000,18:2938.
  • 10Cavanna L,Zaniboni F,Lazzaro A,et al.Oxaliplatin,5-fluoriouracil and leucovorin in patients with advanced or metastatic gastric cancer[J].Proc Am Soc Clin Oncol,2004,23:4068.

二级参考文献15

  • 1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
  • 2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
  • 3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
  • 4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
  • 5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
  • 6Bleiberg H, Oxaliplatin(L-OHP) :a hey, reality in colorectal cancer[J].Br J Cancer, 1998,77 ( Supple 4 ) : 1 - 3.
  • 7De Cramont A,Figer A,Seymonr M,et al. Luecouorin and fluorouracil with or without Oxaliplatin as first-line treatment in advanced eoloreetal cancer[ J]. J Clin Oncol ,2000,18 :2938 - 2947.
  • 8孙燕,周际昌.临床肿瘤内科手册[M]人民卫生出版社,1996.
  • 9Tetsuhiko Shirasaka,Yuji Shimamoto,Hideyuki Ohshimo,Hiroko Saito,Masakazu Fukushima. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo[J] 1993,Cancer Chemotherapy and Pharmacology(3):167~172
  • 10陆建伟,黄富麟,郑秀立,冯继峰.含羟基喜树碱联合治疗方案治疗晚期胃肠道癌临床观察[J].中国肿瘤临床,1998,25(3):232-235. 被引量:31

共引文献422

同被引文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部